Tablets are used to treat certain bladder problems
New Delh: Drug maker Lupin on Monday said it has launched Mirabegron extended-release tablets (25 mg) in the US market.
The Mumbai-based drug maker has introduced the medication after receiving an approval from the US Food and Drug Administration (USFDA), Lupin said in a statement.
The company’s product is a generic equivalent of Astellas Pharma Global Development, Inc’s Myrbetriq extended-release tablets, it added.
Mirabegron extended-release tablets are used to treat certain bladder problems including overactive bladder.
Lupin shares were trading 3.38 per cent up at Rs1,599.35 apiece on the BSE.
Discover more from Businessbenchmark News
Subscribe to get the latest posts sent to your email.